'); } if( partner == 'netscape' ) { document.write(''); } if (document.cookie.indexOf('partner_session=earthlink') != -1) { document.write(''); } if (document.cookie.indexOf('partner_session=msnbc') != -1) { var _rsCI='us-forbes'; var _rsCG='msnbc_hat_test'; var _rsDT=1; var _rsSI=escape(window.location); var _rsLP=location.protocol.indexOf('https')>-1?'https:':'http:'; var _rsRP=escape(document.referrer); var _rsND=_rsLP+'//secure-us.imrworldwide.com/'; if (parseInt(navigator.appVersion)>=4) { var _rsRD=(new Date()).getTime(); var _rsSE=1; var _rsSV=''; var _rsSM=1.0; _rsCL='<\/scr'+'ipt>'; } else { _rsCL=''; } //document.write(_rsCL); document.write('
'); } if (document.cookie.indexOf('partner_session=compuserve') != -1) { document.write(''); } // -->
 
Click Here
 
   
 
Jump | Free Trial Issue
Search Quote
U.S.  |  EUROPE  |  ASIA HOME PAGE FOR THE WORLD'S BUSINESS LEADERS
  
Home > Technology > Sciences & Medicine

   
   Pharmaceuticals
Amgen (And Biotech) Are Growing Up
Looking at its pipeline, and its purchase of Tularik, Amgen is looking more like old-line pharma companies.

Monday Matchup
Amgen Vs. Pfizer 		  
Amgen Vs. Pfizer
 
Pharmaceuticals
New Drugs To Watch 		   Pharmaceuticals
New Drugs To Watch: Three Winners
 
 

Inside Sciences and Medicine

 
Stopping SARS  |  The Business of Allergies  |  Nanotech: A Thousand Dots of Light
Where Are Cancer's Miracle Drugs  |  The Tort Mess
 
 
Innovators and Innovations >

Creating A Killer Product
Liftoff!
Disruption High and Low
Spice For Your Smile
Curb Spam By Charging The Sender
 
 
Sciences & Medicine Headlines From Reuters >

4:11 AM U.S. firm Buckeye to cut jobs, close Irish factory
3:30 AM German Curasan rises on U.S. nod for bone material
2:12 AM PRESS DIGEST - Wall Street Journal - April 1
12:53 AM Aventis completes sale of Aventis Behring unit
7:50 PM Eyetech executives adopt stock trading plans
 
 
TechWeb @ Forbes.com

Tech Stocks: Losing Day Ends Losing Quarter
IBM Opens Up Power Processor Design
Online Directory For IT Health Standards Unveiled
Report: Massachusetts Tops In High Tech
Windows Vs. Linux Security: Depends On Who You Ask
 
 
Slashdot @ Forbes.com

Privacy Leak in Mozilla and Mozilla-Based Browsers
VoIP Cell Phones Coming
LoTR:LEGO Originals
Build a Macintosh From Scratch
MS/Waterloo Curriculum Deal On Hold
 
 
The McKinsey Quarterly@Forbes.com  >

Saving Steel
The Answer To Video Piracy
Learning To Grow Again
How Businesses Can Combat Global Disease
Turkey's Quest For Stable Growth
 
 
E-Mail Alerts

Section Alerts
  Technology
  Enterprise Tech   Future Tech   Personal Tech
  Networks   E-Business   Sciences & Medicine
Topic Alerts: Sciences & Medicine
  Alzheimer's   Science   Biotechnology
  Health and Medicine   Drugs   FDA
  Genetics   Medical Innovation   Stem-Cell Research
Enter E-Mail Address                   FAQ  |   Privacy Policy
 
 
 
Promotions

 
 
Subscriptions >

Free Trial Issue of Forbes Forbes Gift Subscription
Subscribe to Newsletters Subscriber Customer Service


ADVERTISEMENT
    
ADVERTISEMENT
Click Here
 
Markets more >
   Video: Soccer's World-Class Valuations
Wall Street Closes Somewhat Lower
 

Quotes/ResearchPeopleLookup Symbol
Quotes & Research
Enter company or fund
Visit Triggernews.com
Free Portfolio Tracker
People Tracker		 Real-Time Portfolio
IT Research Library
Mobile Edition
 
 
 
IT Research Library more >
The World Trade Center Disaster - A Study on...
Keys to Unlocking Your Web Marketing Genius:...
Understanding the Fundamentals of Managed...
Putting Your Plans to the Test: Are You Sure...
Akamai Streaming - When Performance Matters
 
IT Products & Services more >
 
 
Daily Webcasts more >
  Larry Thompson: An Auditor Who Likes Biotech 6:00 PM EST
You've probably never heard of the Aggressive Small Cap Biotech Fund? It's not listed, but the amateur who runs it is up 188% in the last 12 months.
Dr. Faisal Chaudhry: An MD Who Prefers Oil Stocks to Healthcare 6:00 PM EST
His First Forest Fund's top down approach focuses on the forest rather than the trees. His 297% stock return since November 2000 stands tall like a redwood.
Soccer's World-Class Valuations 7:00 PM EST
Paul Maidment explains why Manchester United is a more valuable franchise than the N.Y. Yankees.
U.S. Firms Dominate Forbes 2000 7:00 PM EST
But companies from Japan, Britain, France and Germany also loom large on our new list.
Chuck Carlson: Dow Dogs Can Hunt 5:15 PM EST
The DRIP Investor editor shows that his "worst to first" stock selection theory has some history.
 
Executive Connection more >
  • Immediate Access To News
  • Tailored To Your Industry
  • Free Download
Download Now   |   Learn More
 
Sciences & Medicine Resources more >
 
200 Best Small Companies    500 Largest Privates
Annual Reports    Conference Calls
Corporate Events    International 500
 
Sciences & Medicine Tools
Business School Calculator    RFP Finder
Valuing R&D; Potential    Windows XP ROI Calculator
 
Premium Services
Forbes Services Investing Services
Business Services Lifestyle Services
 
Magazines more >
Free Trial Issue Forbes Magazine
04.12.04 Current Issue
 
The World's 2000 Leading Companies
Wall-to-Wall Wal-Mart
Trading With the Enemy
A Tale of Two Cities
Archive
 
 

 
Ad Information       Forbes.com Wireless       Reprints / Permissions       Subscriber Services      
© 2004 Forbes.com Inc.™      All Rights Reserved       Privacy Statement       Terms, Conditions and Notices 		 
 
    
Online Marketing by Search Engine Optimization
Market data provided by Reuters. Disclaimer
Stock quotes are delayed at least 15 minutes for Nasdaq, at least 20 minutes for NYSE/AMEX.
U.S. indexes are delayed at least 15 minutes with the exception of Nasdaq, Dow Jones Industrial Average and S&P; 500 which are 2 minutes delayed.
Forbes 40 Index powered by Telemet.
News may include latest headlines from Reuters.